JP2022549138A5 - - Google Patents

Info

Publication number
JP2022549138A5
JP2022549138A5 JP2022517337A JP2022517337A JP2022549138A5 JP 2022549138 A5 JP2022549138 A5 JP 2022549138A5 JP 2022517337 A JP2022517337 A JP 2022517337A JP 2022517337 A JP2022517337 A JP 2022517337A JP 2022549138 A5 JP2022549138 A5 JP 2022549138A5
Authority
JP
Japan
Prior art keywords
dna vector
isolated
aav genome
vector according
linear
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2022517337A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022549138A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2020/051507 external-priority patent/WO2021055760A1/en
Publication of JP2022549138A publication Critical patent/JP2022549138A/ja
Publication of JP2022549138A5 publication Critical patent/JP2022549138A5/ja
Priority to JP2025138128A priority Critical patent/JP2025176040A/ja
Pending legal-status Critical Current

Links

JP2022517337A 2019-09-18 2020-09-18 合成dnaベクターおよびその使用法 Pending JP2022549138A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2025138128A JP2025176040A (ja) 2019-09-18 2025-08-21 合成dnaベクターおよびその使用法

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962902084P 2019-09-18 2019-09-18
US62/902,084 2019-09-18
PCT/US2020/051507 WO2021055760A1 (en) 2019-09-18 2020-09-18 Synthetic dna vectors and methods of use

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2025138128A Division JP2025176040A (ja) 2019-09-18 2025-08-21 合成dnaベクターおよびその使用法

Publications (2)

Publication Number Publication Date
JP2022549138A JP2022549138A (ja) 2022-11-24
JP2022549138A5 true JP2022549138A5 (https=) 2023-09-26

Family

ID=74884687

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2022517337A Pending JP2022549138A (ja) 2019-09-18 2020-09-18 合成dnaベクターおよびその使用法
JP2025138128A Pending JP2025176040A (ja) 2019-09-18 2025-08-21 合成dnaベクターおよびその使用法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2025138128A Pending JP2025176040A (ja) 2019-09-18 2025-08-21 合成dnaベクターおよびその使用法

Country Status (12)

Country Link
US (6) US11324839B2 (https=)
EP (1) EP4031168A4 (https=)
JP (2) JP2022549138A (https=)
KR (1) KR20220128607A (https=)
CN (1) CN115066255A (https=)
AU (1) AU2020351204A1 (https=)
CA (1) CA3151464A1 (https=)
GB (2) GB2700048B (https=)
IL (1) IL291437A (https=)
MX (1) MX2022003291A (https=)
TW (1) TW202124722A (https=)
WO (1) WO2021055760A1 (https=)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20210002667A1 (en) * 2018-03-15 2021-01-07 Intergalactic Therapeutics, Inc. Synthetic dna vectors and methods of use
CN109735558B (zh) * 2018-12-12 2022-04-15 中南大学 一种重组car19-il24基因、慢病毒载体、car19-il24-t细胞及应用
KR20220128607A (ko) 2019-09-18 2022-09-21 인터갈락틱 테라퓨틱스, 인크. 합성 dna 벡터 및 사용 방법
US11926842B2 (en) * 2021-02-02 2024-03-12 University Of Massachusetts Use of inverted terminal repeats (ITRS) from adeno-associated virus serotypes 8 and RH.39 in gene therapy vectors
US20240409975A1 (en) * 2021-09-27 2024-12-12 Intergalactic Therapeutics, Inc. Synthetic production of circular dna vectors
WO2023064934A1 (en) * 2021-10-15 2023-04-20 Intergalactic Therapeutics, Inc. Respiratory delivery of therapeutic agents
KR20240128889A (ko) * 2021-12-20 2024-08-27 알데브론 엘엘씨 조작된 박테리아에서 유전자 치료 벡터의 생산
CA3262218A1 (en) 2022-07-19 2024-01-25 Rampart Bioscience, Inc. CIRCULAR NON-IMMUNOGENEOUS NON-VIRAL DNA VECTORS
WO2024039652A1 (en) 2022-08-16 2024-02-22 Aldevron, L.L.C. Cell-free method of producing synthetic circular nucleic acid
WO2024115669A1 (en) * 2022-11-30 2024-06-06 Evaxion Biotech A/S Process for production of synthetic circular dna

Family Cites Families (92)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2488641A (en) * 1947-06-17 1949-11-22 Herschel V Seawright Revolving display rack for showcases
US6027722A (en) 1990-10-25 2000-02-22 Nature Technology Corporation Vectors for gene transfer
US5478745A (en) 1992-12-04 1995-12-26 University Of Pittsburgh Recombinant viral vector system
EP0728202A4 (en) * 1993-11-12 1997-04-23 Univ Case Western Reserve EPISOMIC EXPRESSION VECTOR FOR HUMAN GENE THERAPY
US6825012B2 (en) * 1995-02-23 2004-11-30 Gencell S.A. DNA molecules, preparation and use in gene therapy
FR2731014B1 (fr) * 1995-02-23 1997-03-28 Rhone Poulenc Rorer Sa Molecules d'adn, preparation et utilisation en therapie genique
US5994104A (en) * 1996-11-08 1999-11-30 Royal Free Hospital School Of Medicine Interleukin-12 fusion protein
US7030098B2 (en) 1999-03-12 2006-04-18 The Board Of Trustees Of The Leland Stanford Junior University DNA vaccination for treatment of autoimmune disease
RU2001135838A (ru) 1999-05-28 2004-01-20 Камбрекс Байо Сайенс Инк. (Us) Способы очистки ДНК и очищенная ДНК
EP1224313A1 (en) * 1999-10-07 2002-07-24 University of Iowa Research Foundation Adeno-associated viruses and uses thereof
AU2001288839A1 (en) 2000-09-08 2002-03-22 The General Hospital Corporation Self-rearranging dna vectors
US20070196838A1 (en) 2000-12-08 2007-08-23 Invitrogen Corporation Methods and compositions for synthesis of nucleic acid molecules using multiple recognition sites
AU2002247014A1 (en) 2001-01-19 2002-07-30 Genetica, Inc. Methods and reagents for amplification and manipulation of vector and target nucleic acid sequences
FR2821855B1 (fr) * 2001-03-09 2004-04-02 Cayla Genes synthetiques et plasmides bacteriens depourvus de cpg
WO2004020605A2 (en) 2002-08-29 2004-03-11 The Board Of Trustees Of The Leland Stanford Junior University Circular nucleic acid vectors, and methods for making and using the same
US7595303B1 (en) 2002-09-05 2009-09-29 University Of South Florida Genetic adjuvants for immunotherapy
US20050069991A1 (en) * 2003-03-25 2005-03-31 Hyman Edward D. Method for plasmid preparation by conversion of open circular plasmid to supercoiled plasmid
AT412400B (de) 2003-05-08 2005-02-25 Mayrhofer Peter Mag Dr Minicircle-herstellung
US8802643B1 (en) 2003-05-30 2014-08-12 University Of South Florida Method for the treatment of malignancies
EP1486567A1 (en) 2003-06-11 2004-12-15 Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts Improved adeno-associated virus (AAV) vector for gene therapy
GB0315160D0 (en) * 2003-06-28 2003-08-06 Royal Holloway University Of L In vitro amplification of DNA
EA010836B1 (ru) 2004-08-19 2008-12-30 Нейче Текнолоджи Корп. Способ ферментации плазмидной днк
BRPI0515777A (pt) 2004-12-11 2008-08-05 Cytogenix Inc biossìntese isenta de células de ácido nucléico de alta qualidade e usos dos mesmos
US7796986B2 (en) * 2005-03-11 2010-09-14 Atc Technologies, Llc Modification of transmission values to compensate for interference in a satellite down-link communications
US7622252B2 (en) 2005-06-10 2009-11-24 Baylor College Of Medicine Generation of minicircle DNA with physiological supercoiling
WO2007018744A2 (en) * 2005-08-03 2007-02-15 Cytogenix, Inc. Cell-free biosynthesis of nucleic acid
US20080318283A1 (en) 2006-02-01 2008-12-25 Clague P. Hodgson Fermentation Process for Continuous Plasmid Dna Production
US9017966B2 (en) 2007-05-23 2015-04-28 Nature Technology Corporation E. coli plasmid DNA production
EP2333091B1 (en) 2007-05-29 2017-06-21 Nature Technology Corporation Vectors and methods for genetic immunization
AU2009231171A1 (en) 2008-04-02 2009-10-08 Fondazione Telethon Method of treating genetic disorders
US8945885B2 (en) 2008-07-03 2015-02-03 The Board Of Trustees Of The Leland Stanford Junior University Minicircle DNA vector preparations and methods of making and using the same
US8921072B2 (en) * 2008-09-02 2014-12-30 General Electric Compnay Methods to generate DNA mini-circles
US8486630B2 (en) * 2008-11-07 2013-07-16 Industrial Technology Research Institute Methods for accurate sequence data and modified base position determination
US9045759B2 (en) 2009-01-21 2015-06-02 James Arthur Williams DNA plasmids with improved copy number
GB0901593D0 (en) 2009-01-30 2009-03-11 Touchlight Genetics Ltd Production of closed linear DNA
JP2013507934A (ja) 2009-10-16 2013-03-07 ベイラー カレッジ オブ メディスン 遺伝子療法適用のためのスーパーコイル状ミニサークルdna
US9506082B2 (en) 2010-04-12 2016-11-29 Nature Technology Corporation Eukaryotic expression vectors resistant to transgene silencing
GB201013153D0 (en) 2010-08-04 2010-09-22 Touchlight Genetics Ltd Primer for production of closed linear DNA
EP2439276A1 (de) * 2010-10-05 2012-04-11 Rentschler Biotechnologie GmbH Verfahren zur semi-synthetischen Herstellung hochreiner "MiniCircle" DNA-Vektoren aus Plasmiden
EP2500434A1 (en) 2011-03-12 2012-09-19 Association Institut de Myologie Capsid-free AAV vectors, compositions, and methods for vector production and gene delivery
JP6333730B2 (ja) 2011-12-12 2018-05-30 ザ トラスティーズ オブ ザ ユニバーシティ オブ ペンシルバニア 改善されたil−12遺伝子構築物を含む組成物、及びそれを用いたワクチン、免疫治療剤及び方法
WO2013119371A2 (en) 2012-02-10 2013-08-15 The Board Of Trustees Of The Leland Stanford Junior University Mini-intronic plasmid vectors
US20140350087A9 (en) 2012-03-22 2014-11-27 Halozyme, Inc. Oncovector Nucleic Acid Molecules and Methods of Use
CA2876860A1 (en) 2012-05-30 2013-12-05 Baylor College Of Medicine Supercoiled minivectors as a tool for dna repair, alteration and replacement
WO2014077863A1 (en) 2012-11-19 2014-05-22 Nature Technology Corporation Replicative minicircle vectors with improved expression
WO2014093894A2 (en) 2012-12-13 2014-06-19 The Trustees Of The University Of Pennsylvania Dna antibody constructs and method of using same
CA2923957C (en) * 2013-01-18 2021-08-31 London School Of Hygiene And Tropical Medicine Glycosylation method
US9701981B2 (en) 2013-03-15 2017-07-11 The Board Of Trustees Of The Leland Stanford Junior University Nucleosome-excluding sequences (NES) as a DNA spacer in vectors results in prolonged transgene expression in eukaryotic cells
GB201307075D0 (en) 2013-04-19 2013-05-29 Mayrhofer Peter Plasmid for minicircle production
EP2994531B1 (en) 2013-05-10 2018-03-28 Sangamo Therapeutics, Inc. Delivery methods and compositions for nuclease-mediated genome engineering
CN104342453A (zh) 2013-08-06 2015-02-11 深圳先进技术研究院 含基因工程抗体基因表达盒的微环dna重组母质粒、含该表达盒的微环dna及应用
WO2016094639A1 (en) 2014-12-10 2016-06-16 Wisconsin Alumni Research Foundation Mini-intronic plasmid dna vaccines in combination with lag3 blockade
WO2016120186A1 (en) * 2015-01-27 2016-08-04 F. Hoffmann-La Roche Ag Recombinant hbv cccdna, the method to generate thereof and the use thereof
CA2975855C (en) 2015-02-04 2025-09-23 Twist Bioscience Corporation SYNTHETIC GENE COMPOSITIONS AND ASSEMBLY METHODS
GB201502137D0 (en) * 2015-02-09 2015-03-25 Ucl Business Plc Treatment
US10426847B2 (en) 2015-03-26 2019-10-01 Oncosec Medical Incorporated Method for the treatment of malignancies
EP3294309A4 (en) 2015-05-14 2019-01-16 St. Jude Children's Research Hospital, Inc. NUCLEIC ACID MOLECULES WITH SPACERS AND METHOD FOR USE THEREOF
ES3063691T3 (en) * 2015-09-22 2026-04-20 Univ Wuerzburg J Maximilians A method for high level and stable gene transfer in lymphocytes
CA3005474A1 (en) 2015-11-19 2017-05-26 The Trustees Of The University Of Pennsylvania Compositions and methods for correction of heritable ocular disease
EP3390643B8 (en) 2015-12-18 2023-08-02 OncoSec Medical Incorporated Plasmid constructs for heterologous protein expression and methods of use
EP3205356A1 (en) 2016-02-10 2017-08-16 Onkoloski Institut Ljubljana Plasmid expression vector encoding human interleukin 12 under transcriptional control of p21 promoter and without antibiotic resistance for cancer gene therapy and other uses thereof
MX2018010633A (es) 2016-03-03 2019-06-13 Univ Massachusetts Acido desoxirribonucleico (adn) lineal duplex de extremos cerrados para transferencia genica no viral.
US10077459B2 (en) 2016-05-04 2018-09-18 General Electric Company Cell-free protein expression using rolling circle amplification product
US11060137B2 (en) 2016-12-14 2021-07-13 Codex Dna, Inc. Methods for assembling DNA molecules
JP6960684B2 (ja) 2017-02-28 2021-11-05 オリシロジェノミクス株式会社 環状dnaの複製または増幅方法
US20180305701A1 (en) * 2017-03-14 2018-10-25 Baylor College Of Medicine Targeting minivectors to specific tissue using shape
EP3600446A1 (en) 2017-03-21 2020-02-05 Michalakis, Stylianos Gene therapy for the treatment of cngb1-linked retinitis pigmentosa
CN110709095B (zh) 2017-04-05 2024-05-03 马萨诸塞大学 小基因治疗
CN108728465A (zh) 2017-04-14 2018-11-02 深圳新诺微环生物科技有限公司 一种表达靶细胞-效应细胞桥接器的微环dna载体及其制备方法和应用
CN111133109A (zh) 2017-06-13 2020-05-08 昂科赛克医疗公司 用于免疫调节蛋白表达的多基因构建体和其使用方法
FI3638776T3 (fi) * 2017-06-14 2025-12-09 Univ Dresden Tech Menetelmiä ja välineitä genomien geneettiseen muokkaamiseen hyödyntäen suunnittelu-DNA:ta rekombinoivia entsyymejä
CA3075168A1 (en) * 2017-09-08 2019-03-14 Generation Bio Co. Modified closed-ended dna (cedna)
DK3456821T4 (da) 2017-09-19 2024-04-15 Deutsches Krebsforsch Ikke-integrerende dna-vektorer til genetisk modifikation af celler
WO2019057774A1 (en) 2017-09-19 2019-03-28 Deutsches Krebsforschungszentrum NON-INTEGRATING DNA VECTORS FOR THE GENETIC MODIFICATION OF CELLS
US20200048716A1 (en) 2017-11-03 2020-02-13 Twister Biotech, Inc Using minivectors to treat ovarian cancer
US20210002667A1 (en) * 2018-03-15 2021-01-07 Intergalactic Therapeutics, Inc. Synthetic dna vectors and methods of use
DK3768846T5 (da) 2018-03-21 2024-08-19 Aldevron L L C Virale og ikke-virale nanoplasmidvektorer med forbedret produktion
WO2019226650A1 (en) 2018-05-23 2019-11-28 Modernatx, Inc. Delivery of dna
WO2020077159A1 (en) 2018-10-10 2020-04-16 The Johns Hopkins University POLY(Beta-AMINO ESTER) NANOPARTICLES FOR THE NON-VIRAL DELIVERY OF PLASMID DNA FOR GENE EDITING AND RETINAL GENE THERAPY
CA3115658A1 (en) 2018-10-12 2020-05-22 Children's Hospital Medical Center Modular expression systems for gene expression and methods of using same
US20210383891A1 (en) 2018-10-19 2021-12-09 New England Biolabs, Inc. Improved Ordered Assembly of Multiple DNA Fragments
CN109402168A (zh) 2018-10-30 2019-03-01 深圳新诺微环生物科技有限公司 微环dna表达连接her2阳性细胞与效应细胞的桥接分子及其应用
TWI850282B (zh) 2018-11-27 2024-08-01 香港商弘年發展有限公司 用於治療癌症之質體建構體和使用方法
CN111378677A (zh) 2018-12-27 2020-07-07 南京中科游子生物技术研究院有限公司 一种dna组装的方法及其应用
CA3125347A1 (en) 2019-01-15 2020-07-23 University Of Maryland, Baltimore County A method for assembling circular and linear dna molecules in an ordered manner
EP3931319A1 (en) 2019-02-28 2022-01-05 ProteoNic Biotechnology IP B.V. Self-immolative plasmid backbone
EP3956452A4 (en) 2019-04-19 2023-03-15 University of Massachusetts GENE THERAPIES FOR USHER SYNDROME (USH2A)
EP3956453A4 (en) 2019-04-19 2023-02-22 University of Massachusetts GENE THERAPIES FOR USHER SYNDROME (USH1B)
CA3137135A1 (en) 2019-04-19 2020-10-22 University Of Massachusetts Gene therapies for stargardt disease (abca4)
CN110564751A (zh) 2019-09-03 2019-12-13 深圳新诺微环生物科技有限公司 微环dna疫苗设计及应用
CN110684798A (zh) 2019-09-03 2020-01-14 深圳新诺微环生物科技有限公司 肌肉靶向的微环dna基因治疗
KR20220128607A (ko) 2019-09-18 2022-09-21 인터갈락틱 테라퓨틱스, 인크. 합성 dna 벡터 및 사용 방법

Similar Documents

Publication Publication Date Title
JP2022549138A5 (https=)
JP2021516953A5 (https=)
US11661596B2 (en) Targeted RNA editing by leveraging endogenous ADAR using engineered RNAs
JP2022517174A5 (https=)
CN113272428A (zh) 核酸构建体和使用方法
SG11202111375RA (en) Novel aav capsids and compositions containing same
JP2018513682A5 (https=)
CN114591952B (zh) 一种组织特异性表达的环状rna分子及其应用
JP2021516953A (ja) 合成dnaベクターおよびその使用
CA3145112A1 (en) Engineered nucleic acid regulatory element and methods of uses thereof
WO2015196179A1 (en) Methods of packaging multiple adeno-associated virus vectors
US20240309368A1 (en) Targeted rna editing by leveraging endogenous adar using engineered rnas
CN111218446A (zh) 一种肝脏特异性启动子及其应用
CN118202045A (zh) 工程化的adar募集rna及其使用方法
CN116710079A (zh) 包含经修饰的核苷酸的脂质纳米颗粒
US20240226296A9 (en) Ert2 mutants and uses thereof
TW202223095A (zh) 串聯指環病毒構築體
JP2025524620A (ja) 暗号化rna及びその使用方法
CN115806984A (zh) 环状rna及载体和载体的应用
US12116578B2 (en) Methods and systems of PCR-based recombinant adeno-associated virus manufacture
US20240150433A1 (en) Ert2 mutants and uses thereof
WO2024259263A2 (en) Programmable mirna-dependent gene expression
US20220136036A1 (en) Methods and systems of pcr-based recombinant adeno-associated virus manufacture
US20260124230A1 (en) Gene editing for controlled expression of episomal genes
JP2025534660A (ja) エピソーム遺伝子を制御発現させるための遺伝子編集